Olivier Van Till

Olivier van Till has worked in the pharmaceutical industry since 2009, as a Medical Director in Pharmacovigilance and Medical & Development at Astellas Europe in Leiden, the Netherlands and from 2017 to 2021 at Astellas Headquarters in Tokyo Japan, where he helped set up global development capabilities. In his role of Global Medical Lead he conducted drug development projects from preclinical to approval phases in various therapeutic areas, including urology, nephrology, infectious diseases, pain, pediatrics and immunology.

Before his work in the pharmaceutical industry he worked as a medical doctor in the fields of General Surgery and Urology. He received his Medical degree and PhD in Immunology/Surgery, Dissertation: “Attack and Defense, the Immune Response to Secondary Peritonitis” from the University of Amsterdam, the Netherlands. He completed a post-doctoral program Advanced Studies in Pharmaceutical Medicine and Medicines Development at the European Center of Pharmaceutical Medicine at the University of Basel, Switzerland.